Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Combined Treatment Busts DVT Thrombus

By HospiMedica staff writers
Posted on 31 Mar 2008
A system to treat deep vein thrombosis (DVT) combines the use of clot-busting drugs with a mechanical dispersion device to break up the clot faster.

The Trellis-8 Peripheral Infusion System is an advanced isolated thrombolysis catheter with two occluding balloons, drug infusion holes between the balloons, and mechanical drug dispersion capabilities. More...
The device is guided directly to the clot via the catheter placed in the vein. The system is positioned at the site of the clot and a balloon is inflated on both sides of the DVT to prevent debris from traveling to other parts of the body, as well as to isolate the treatment zone, reducing the risk of the infused drug causing subsequent bleeding. Next, a dispersion wire is fed through the catheter, where it begins to rotate, mixing the clot-busting drug within the thrombus; the pieces are then aspirated into the catheter and removed from the body. Because the device disperses the drug throughout the clot, it allows the clot-dissolving drug to work much more quickly, reducing the amount of drug used, which may lead to a decrease in the risk of bleeding. The Trellis device has been found to remove the blood clot and restores blood flow much quicker than the current catheter-directed thrombolysis (CDT) technique, which uses a drug alone and can take as long as two to three days to be effective with the patient in an intensive care unit (ICU). The Trellis-8 Peripheral Infusion System is a product of Bacchus Vascular (Santa Clara, CA, USA) and has been approved by the U.S. Food and Drug Administration (FDA).

"It gets the clot out right away, restoring blood flow in the vein while the patient's blood becomes sufficiently thinned by anticoagulation medication to prevent blood clots in the future. Patients experience dramatic relief of pain, swelling, and skin discoloration in just a few hours,” said Gerard J. O'Sullivan, M.D., M.B., an interventional radiologist at Galway University Hospital (Ireland). "The procedure is now so commonplace where I work that the ER, oncology, and general medicine doctors all refer patients directly to me for this procedure because it works so well and is so safe.”

DVT can lead to serious consequences, including pulmonary embolism (PE) or post-thrombotic syndrome (PTS). The standard initial treatment with blood thinners is important to prevent a life-threatening PE, but does not treat the existing clot. Removing these clots is important because about 50% of the time, untreated clots will cause PTS, a condition characterized by chronic leg pain, swelling, and ulcers. Even though the clot may eventually dissolve on its own, in the meantime the veins are permanently damaged due to a combination of vein valve damage and blocked blood flow in the vein from residual thrombus.


Related Links:
Bacchus Vascular
Galway University Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.